Dr Lalchandani Labs (BOM:541299) Total Liabilities : ₹54.52 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Total Liabilities?

Dr Lalchandani Labs's Total Liabilities for the quarter that ended in Mar. 2024 was ₹54.52 Mil.

Dr Lalchandani Labs's quarterly Total Liabilities declined from Mar. 2023 (₹87.96 Mil) to Sep. 2023 (₹83.18 Mil) and declined from Sep. 2023 (₹83.18 Mil) to Mar. 2024 (₹54.52 Mil).

Dr Lalchandani Labs's annual Total Liabilities increased from Mar. 2022 (₹76.38 Mil) to Mar. 2023 (₹87.96 Mil) but then declined from Mar. 2023 (₹87.96 Mil) to Mar. 2024 (₹54.52 Mil).

Dr Lalchandani Labs Total Liabilities Historical Data

The historical data trend for Dr Lalchandani Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Total Liabilities Chart

Dr Lalchandani Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

33.94

56.44

76.38

87.96

54.52

Dr Lalchandani Labs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Total Liabilities	Get a 7-Day Free Trial														76.38	92.70	87.96	83.18	54.52

Dr Lalchandani Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Dr Lalchandani Labs's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	50.301	+	(2.629	+	1.588
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	54.52

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	149.917	-	95.399
	=	54.52

Dr Lalchandani Labs's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	50.301	+	(2.629	+	1.588
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	54.52

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	149.917	-	95.399
	=	54.52

Dr Lalchandani Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines